- PAH drug-device developer SteadyMed prices IPO
- Wockhardt's compliance improving as FDA woes ease?
- USV chief on the metformin 'marathon' & shape of India's diabetes market
- FDA pledges to work with drug makers on shortages
ANALYSIS Other Informa Analysis
COMMENT Other Informa Comment
- Profile: Novartis India boss on a working mother, karma & his wrist watch
- INTERVIEW: Celgene's head dealmaker strikes a fair balance